Mumps outbreaks across England and Wales in 2004: Observational study

BMJ

Volumn 330, Issue 7500, 2005, Pages 1119-1120

  Savage, Emma ^a   Ramsay, Mary ^a   White, Joanne ^a   Beard, Stuart ^a   Lawson, Heather ^a   Hunjan, Rashpal ^a   Brown, David ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL OBSERVATION; HIGH RISK POPULATION; INCIDENCE; MUMPS; POLICY; PRIORITY JOURNAL; UNITED KINGDOM; VACCINATION; ADOLESCENT; ADULT; EPIDEMIC; HUMAN;

ADOLESCENT; ADULT; DISEASE OUTBREAKS; ENGLAND; HUMANS; INCIDENCE; MUMPS; WALES;

EID: 18744409355     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.330.7500.1119     Document Type: Article

References (5)

1. Gay NJ, Miller E, Hesketh L, Morgan-Capner P, Ramsay M, Cohen B, et al. Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule. Commun Dis Rep CDR Rev 1997; 7(2):R21–R26.
2. Communicable Disease Surveillance Centre. Laboratory confirmed cases of measles, mumps and rubella, England and Wales: July to September 2002. Commun Dis Rep CDR Wkly 2002; 12(48).
3. Gay NJ, Valambia S, Galasko D, Miller E. Selective rubella vaccination programmes: a survey of districts in England and Wales. Commun Dis Rep CDR Rev 1994; 4(7):R77–R79.
4. Communicable Disease Surveillance Centre. Fall in MMR vaccine coverage reported as further evidence of vaccine safety is published. Commun Dis Rep CDR Wkly 1999; 9(26): 227, 230.
5. Harling R, White JM, Ramsay ME, MacSween K, van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 2005 (in press).